Patient Guide: HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 15 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04257162
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Cancer
Phase: NA

Where You Can Participate

This study is available at 15 locations across the country.

Top locations include:
  • • Badalona, Barcelona
  • • Barcelona, Barcelona
  • • Barcelona, Barcelona
  • • And 12 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) - Join Clinical Trial NCTNCT04257162

How to Join This Clinical Trial - NCTNCT04257162

Learn how to participate in this NA trial studying an investigational therapy for Metastatic Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Cancer
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04257162 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Badalona, Barcelona - Spain

Status: Contact for availability

Clinical Research Site

Barcelona, Barcelona 08003 - Spain

Status: Contact for availability

Clinical Research Site

Barcelona, Barcelona 08036 - Spain

Status: Contact for availability

Clinical Research Site

Jerez de la Frontera, Cadiz 11407 - Spain

Status: Contact for availability

Clinical Research Site

Santa Cruz de Tenerife, Canary Islands 38320 - Spain

Status: Contact for availability

Clinical Research Site

Lleida, Lleida - Spain

Status: Contact for availability

Clinical Research Site

Madrid, Madrid 28046 - Spain

Status: Contact for availability

Clinical Research Site

Seville, Sevilla - Spain

Status: Contact for availability

Clinical Research Site

Valencia, Valencia 46009 - Spain

Status: Contact for availability

Clinical Research Site

Barcelona, - Spain

Status: Contact for availability

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Metastatic Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships